Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001104659-21-016820

Director bought 2,979,566 shares at $18.00 ($53,632,188)

  • Director acquired 7,143,025 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. Director 2021-02-09 Conversion +1,664,549 1,664,549 I
RA CAPITAL MANAGEMENT, L.P. Director 2021-02-09 Conversion +280,330 280,330 I
RA CAPITAL MANAGEMENT, L.P. Director 2021-02-09 Conversion +3,784,120 5,448,669 I
RA CAPITAL MANAGEMENT, L.P. Director 2021-02-09 Conversion +1,414,026 1,694,356 I
RA CAPITAL MANAGEMENT, L.P. Director 2021-02-09 Purchase +2,848,596 $18.00 $51,274,728 8,297,265 I
RA CAPITAL MANAGEMENT, L.P. Director 2021-02-09 Purchase +130,970 $18.00 $2,357,460 1,825,326 I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2021-02-09 Conversion · Series A-2 Preferred Stock −22,637,875 0 I
RA CAPITAL MANAGEMENT, L.P. Director 2021-02-09 Conversion · Series A-2 Preferred Stock −3,812,500 0 I
RA CAPITAL MANAGEMENT, L.P. Director 2021-02-09 Conversion · Series B Preferred Stock −51,464,036 0 I
RA CAPITAL MANAGEMENT, L.P. Director 2021-02-09 Conversion · Series B Preferred Stock −19,230,770 0 I
Open-market purchases · 2,979,566 sh · avg $18.00 · $53,632,188
Loading xslF345X03/tm216001-1_4.xml…